CR7589A - Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes - Google Patents
Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantesInfo
- Publication number
- CR7589A CR7589A CR7589A CR7589A CR7589A CR 7589 A CR7589 A CR 7589A CR 7589 A CR7589 A CR 7589A CR 7589 A CR7589 A CR 7589A CR 7589 A CR7589 A CR 7589A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tissular
- anticoagulants
- factors
- directed against
- antibodies directed
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 229940127219 anticoagulant drug Drugs 0.000 title 1
- 102000002262 Thromboplastin Human genes 0.000 abstract 5
- 108010000499 Thromboplastin Proteins 0.000 abstract 5
- 208000004476 Acute Coronary Syndrome Diseases 0.000 abstract 1
- 206010051055 Deep vein thrombosis Diseases 0.000 abstract 1
- 108010054265 Factor VIIa Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000009190 disseminated intravascular coagulation Diseases 0.000 abstract 1
- 229940012414 factor viia Drugs 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Nuevos anticuerpos que se unen con mayor afinidad al complejo del factor VIIa/factor tisular (FVIIa/TF) que al factor tisular (TF) solamente, no compiten por la union a TF con FVII y FX e inhiben la activacion de FX. Los anticuerpos se unen en el sitio de la lesion y previenen el inicio de trombosis. Los anticuerpos se pueden usar para el tratamiento de diversas afecciones tromboticas incluyendo, a modo de ejemplo, trombosis de venas profundas, coagulacion intravascular diseminada y sindrome coronario agudo.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7589A CR7589A (es) | 2004-11-24 | 2004-11-24 | Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7589A CR7589A (es) | 2004-11-24 | 2004-11-24 | Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7589A true CR7589A (es) | 2006-07-14 |
Family
ID=44839260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7589A CR7589A (es) | 2004-11-24 | 2004-11-24 | Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR7589A (es) |
-
2004
- 2004-11-24 CR CR7589A patent/CR7589A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP045467A (es) | Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes | |
| BR0308928A (pt) | Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular | |
| AR109605A2 (es) | Método para tratar enfermedades vasculares periféricas, composición y utilización | |
| WO2010056765A3 (en) | Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agents | |
| CR11486A (es) | Tratamiento de cancer uterino y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes anti-tumorales | |
| BRPI0419206A (pt) | artigo absorvente | |
| DOP2009000283A (es) | Compuestos moduladores de sirtuina | |
| BR112012011042A2 (pt) | cateter de ablação. | |
| BRPI0516764A (pt) | hemostato | |
| ECSP11011349A (es) | Uso de sintético y biológico fungicidas en combinación para controlar hongos dañinos | |
| ECSP11011490A (es) | Uso de sintético y biológico fungicidas en combinación para controlar hongos dañinos | |
| ATE442101T1 (de) | Vorrichtung und kit zur behandlung von stírungen des herzrhythmus-regulierungssystems | |
| MX2019004573A (es) | Metodos para evitar eventos cardiovasculares mediante la reduccion de la proproteinas convertasa subtilisina kexina 9 (pcsk9). | |
| CY1110889T1 (el) | C-αρυλο γλυκοζιτικοι sglt2 αναστολεις και μεθοδος για την παραγωγη τους | |
| DE602007004643D1 (de) | Vorrichtung zur verbesserung der herzklappenfunktion | |
| DE602007009408D1 (de) | Ausführungen von ballonnähten | |
| WO2009042962A3 (en) | Antidotes for factor xa inhibitors and methods of using the same | |
| WO2009017863A3 (en) | Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification | |
| ATE451077T1 (de) | Künstliches blutgefäss | |
| DE602006021290D1 (de) | Modulator von coagulationskaskaden und fibrinolytischen kaskaden | |
| ATE514815T1 (de) | Faserstrukturen mit zusatz mit geringer oberflächenenergie | |
| WO2006114105A3 (en) | Use of modified factor vii for treating bleeding | |
| PH12017502145A1 (en) | Composition and uses thereof | |
| CR7589A (es) | Nuevos anticuerpos dirigidos contra factores tisulares como anticoagulantes | |
| BRPI0607280A2 (pt) | método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |